News archive
19.12.2016
Dear friends! Materia Medica Holding Company wishes you a Merry Christmas and a Happy New Year 2017!
26.04.2016
Start-up meeting associated with initiation of clinical studies of Ergoferon
18.02.2016
Four extensive multicenter randomized trials have been completed which evaluated the safety and efficacy of two release-active drugs – liquid Ergoferon and Rengalin – in children and adults with acute respiratory infections (ARIs).
28.01.2016
Laboratory of Influenza under Pasteur Institute and APcis carried out a study in cooperation with Materia Medica Holding.
05.12.2017
MATERIA MEDICA HOLDING NAMED 2017 BEST EMPLOYER!
31.10.2017
Conference Report: International Scientific and Practical Conference –“The Older Patient. Quality of Life”
16.10.2017
The18th All-Russian Scientific and Practical Neurology Conference with Foreign Guest Speakers – “DAVIDENKOV READINGS 2017”
22.09.2017
Dear Colleagues! Data on the Company’s Products were announced at European Respiratory Society International Congress in Milan, September 9-13.
19.09.2017
Highlights from Symposium on Cellular and Molecular Mechanisms of Movement Disorders held at the 4th National Congress with Foreign Guest Speakers on Parkinson's Disease and Movement Disorders
30.06.2017
Report from Symposium on Medical Comorbidities in Elderly Patients held at the 9th International Congress “Neurorehabilitation 2017”
14.04.2017
Released Activity (Contemporary View of Homeopathy and Non-homeopathy)
24.12.2015
Dear friends! Materia Medica Holding Company wishes you a Merry Christmas and a Happy New Year 2016!
11.11.2015
Officials of Mexico National Institute of Pediatrics confirmed recommendations on Anaferon for children application for prevention and treatment of acute infectious respiratory diseases
12.08.2015
Materia Medica expands manufacturing unit
28.07.2015
3rd Drug Discovery & Therapy World Congress
16.06.2015
First Russian GMP certificate
14.05.2015
7 International Congress of Antibodies